Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, meaning it starts in the liver itself. It typically develops in people with chronic liver disease, such as those with long-term hepatitis infections or cirrhosis (severe liver scarring). Early detection is crucial for more effective treatment options and a better outlook.

What is Hepatocellular Carcinoma?

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, which means it begins in the liver's main cells, called hepatocytes. Unlike cancers that spread to the liver from other parts of the body, HCC originates there. It often develops in livers that are already damaged, usually by long-term conditions like chronic hepatitis or cirrhosis.

The liver is a vital organ located in the upper right part of your abdomen, responsible for many essential functions, including filtering toxins, producing bile for digestion, and storing energy. When liver cells become cancerous, they can grow and form tumors. HCC is distinct from metastatic liver cancer, which is cancer that started in another organ (like the colon or breast) and then spread to the liver. Because HCC starts in the liver, its treatment and outlook are specific to this type of cancer. This type of cancer is often found in people who have existing liver conditions. The ongoing damage and repair processes in a diseased liver can sometimes lead to abnormal cell growth, increasing the risk of HCC.

Symptoms

In its early stages, hepatocellular carcinoma (HCC) often causes no noticeable symptoms, making it difficult to detect without regular screening. As the cancer grows, symptoms may begin to appear, often related to the liver's declining function or the tumor's presence. These can include general discomfort and signs of liver impairment.

When symptoms do occur, they can be vague and may include unexplained weight loss and a loss of appetite. You might also experience nausea and vomiting, along with a general feeling of weakness and fatigue. As the liver's health worsens, you might notice pain in your upper abdomen, especially on the right side, or a feeling of fullness. Your abdomen might also swell due to fluid buildup (ascites) or an enlarged liver. Some people may develop jaundice, which is a yellowing of the skin and the whites of the eyes, caused by a buildup of bilirubin (a waste product) in the blood. Other signs can include dark urine, pale or chalky stools, and sometimes a fever.

Causes & risk factors

Hepatocellular carcinoma (HCC) is primarily caused by chronic liver damage and inflammation, with cirrhosis (severe scarring of the liver) being the strongest risk factor. Conditions that lead to cirrhosis, such as long-term viral infections or excessive alcohol use, significantly increase your chances of developing HCC. Understanding these factors can help in prevention and early detection.

The most common causes and risk factors for HCC include: * **Chronic Hepatitis B (HBV) or Hepatitis C (HCV) infection:** Long-term infection with these viruses is a leading cause worldwide. The viruses cause ongoing inflammation and damage to the liver, which can lead to cirrhosis and eventually HCC. * **Cirrhosis:** This condition involves severe scarring of the liver, often caused by chronic liver diseases. Most people who develop HCC already have cirrhosis. Causes of cirrhosis include chronic hepatitis, long-term heavy alcohol use, nonalcoholic fatty liver disease (NAFLD), hemochromatosis (a disorder where too much iron builds up in the body), and primary biliary cholangitis (a chronic liver disease that slowly destroys the bile ducts). Other risk factors can include certain inherited liver diseases and exposure to aflatoxins, which are toxins produced by a fungus that can grow on crops like peanuts and corn. Obesity and type 2 diabetes are also linked to an increased risk of HCC, often because they can lead to nonalcoholic fatty liver disease (NAFLD) and subsequently, cirrhosis.

How it's diagnosed

Diagnosing hepatocellular carcinoma (HCC) typically involves a combination of physical exams, blood tests, and imaging scans. Because HCC often develops in people with existing liver disease, regular screening is crucial for early detection. If a suspicious area is found, a biopsy may be performed to confirm the diagnosis and determine the cancer type.

The diagnostic process usually starts with a physical exam, where your doctor will check for signs of liver disease, such as an enlarged liver or spleen, or fluid in the abdomen. They will also ask about your medical history and any symptoms you might be experiencing. Blood tests are often used, including tests for liver function and a specific tumor marker called alpha-fetoprotein (AFP). High levels of AFP can sometimes indicate HCC, though not always. Imaging tests are critical for finding tumors and assessing their size and location. These may include ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI). In some cases, especially if imaging results are unclear, a liver biopsy may be needed. During a biopsy, a small sample of liver tissue is removed, usually with a needle, and examined under a microscope by a pathologist to confirm the presence of cancer cells. This helps to accurately diagnose HCC and rule out other conditions.

Treatment options

Treatment for hepatocellular carcinoma (HCC) depends on several factors, including the cancer's stage, the extent of liver damage, and your overall health. Options range from surgical removal of the tumor to less invasive local therapies, as well as systemic treatments that target cancer cells throughout the body. Your care team will recommend the most suitable approach.

For early-stage HCC, especially when the liver function is good, surgical options offer the best chance for a cure. These include: * **Partial hepatectomy (resection):** This surgery removes the part of the liver containing the tumor. It's an option if the tumor is small, the liver function is good, and there is enough healthy liver tissue remaining. * **Liver transplant:** For some people with small tumors or a limited number of tumors, a liver transplant can remove the diseased liver entirely and replace it with a healthy donor liver. This not only removes the cancer but also cures the underlying liver disease. Other treatments focus on destroying the cancer cells or controlling their growth: * **Ablation:** These procedures destroy tumors without removing them. Examples include radiofrequency ablation (using heat), cryoablation (using extreme cold), or injecting ethanol directly into the tumor. * **Embolization:** This involves blocking the blood supply to the tumor. Transarterial chemoembolization (TACE) delivers chemotherapy drugs directly to the tumor through its blood vessels, then blocks the vessels. Transarterial radioembolization (TARE) uses radioactive beads. * **Radiation therapy:** High-energy beams are used to kill cancer cells or shrink tumors. * **Targeted drug therapy:** These medications specifically attack cancer cells by interfering with their growth signals. Sorafenib is an example of a targeted drug used for HCC. * **Immunotherapy:** These drugs help your body's immune system recognize and fight cancer cells. * **Chemotherapy:** While less commonly used for HCC than other cancers, chemotherapy drugs may be used in some situations to kill cancer cells.

Recovery & outlook

The recovery and outlook for hepatocellular carcinoma (HCC) vary significantly based on the cancer's stage at diagnosis, the health of your liver, and how well you respond to treatment. Early detection and prompt treatment generally lead to a better prognosis. Regular follow-up care is essential to monitor for recurrence and manage liver health.

After treatment, recovery involves managing any side effects and allowing your body to heal. This can be a long process, especially after surgery or a liver transplant. Your healthcare team will provide guidance on diet, activity levels, and medication management. For many people, HCC can be a challenging disease, and the outlook depends heavily on whether the cancer is found early. If HCC is detected at an early stage, when it's small and confined to the liver, treatments like surgery or transplant can offer a chance for a cure or long-term survival. However, if the cancer has grown large or spread, treatment focuses more on controlling the disease and improving quality of life. Even after successful treatment, there is a risk of HCC returning, especially if the underlying liver disease persists. Therefore, regular follow-up appointments, including imaging scans and blood tests, are crucial. These check-ups help monitor your liver health and detect any new or recurring cancer as early as possible.

When to see a doctor

You should see a doctor if you experience persistent or new symptoms that could indicate liver problems or hepatocellular carcinoma (HCC), especially if you have known risk factors like chronic hepatitis or cirrhosis. Early medical evaluation is important for accurate diagnosis and timely intervention. Do not delay seeking care for concerning symptoms.

It's important to contact your doctor if you notice any of the following symptoms: * Unexplained weight loss or loss of appetite. * Persistent pain or discomfort in your upper right abdomen. * Yellowing of your skin or the whites of your eyes (jaundice). * Dark urine or pale, chalky stools. * Unusual fatigue or weakness. * Abdominal swelling or a feeling of fullness. If you have chronic liver disease, such as hepatitis B or C, or cirrhosis, your doctor will likely recommend regular screening for HCC, even if you don't have symptoms. These screenings typically involve blood tests and imaging studies. Following your doctor's recommendations for screening is vital for detecting HCC at its earliest, most treatable stages. If you have any sudden or severe symptoms, such as acute abdominal pain or sudden worsening of jaundice, seek immediate medical attention.

Frequently asked questions

Can hepatocellular carcinoma be cured?

Yes, hepatocellular carcinoma (HCC) can be cured, especially when it is detected at an early stage. Treatments like surgical removal of the tumor (resection) or a liver transplant offer the best chance for a cure. However, the possibility of a cure depends on factors such as the size and number of tumors, the overall health of your liver, and whether the cancer has spread.

What is the difference between primary and secondary liver cancer?

Primary liver cancer, like hepatocellular carcinoma (HCC), starts in the liver cells themselves. Secondary liver cancer, also called metastatic liver cancer, is cancer that began in another part of the body (such as the colon, lung, or breast) and then spread to the liver. HCC is a primary liver cancer.

Is hepatocellular carcinoma always linked to cirrhosis?

While most people who develop hepatocellular carcinoma (HCC) also have cirrhosis (severe scarring of the liver), it is not always the case. HCC can sometimes develop in livers without cirrhosis, particularly in individuals with chronic hepatitis B infection. However, cirrhosis remains the strongest risk factor for HCC.

What is alpha-fetoprotein (AFP) and how is it used for HCC?

Alpha-fetoprotein (AFP) is a protein that can be found in higher levels in the blood of some people with hepatocellular carcinoma (HCC). It is used as a tumor marker, meaning it can help doctors screen for HCC, monitor treatment effectiveness, and check for recurrence. However, elevated AFP levels do not always mean HCC is present, and normal levels do not rule it out.

What lifestyle changes can help prevent HCC if I have liver disease?

If you have liver disease, certain lifestyle changes can help reduce your risk of hepatocellular carcinoma (HCC). These include avoiding alcohol, maintaining a healthy weight through diet and exercise, and managing underlying conditions like diabetes. If you have chronic hepatitis B or C, adhering to your prescribed antiviral treatment is crucial to prevent liver damage and reduce HCC risk.

How often should I be screened for HCC if I'm at high risk?

If you are at high risk for hepatocellular carcinoma (HCC), such as having cirrhosis or chronic hepatitis B, your doctor will likely recommend regular screening. This typically involves an ultrasound of the liver and a blood test for alpha-fetoprotein (AFP) every six months. Following your doctor's specific screening schedule is very important for early detection.

Sources

• MedlinePlus — Hepatocellular Carcinoma
• Mayo Clinic — Hepatocellular Carcinoma
• Cochrane Library — Hepatocellular Carcinoma